Due to high mortality rates and the rapid and severe onset of neuronal complications, K18-hACE2 transgenic mice may not be particularly suitable for evaluating certain treatments [65,66] but serve as one of the most used models to study the neurological complications experienced by COVID-19 patients, including anosmia [67]. The gene discussed is KRT18; the disease is COVID-19.